Daré Bioscience Addresses New National Focus on Women’s Health in Virtual Investor “What This Means” Discussion

Daré Bioscience participated in a Virtual Investor 'What This Means' segment in which CEO Sabrina Martucci Johnson discussed the October 19, 2026 Executive Order 14437 on women's health research and care. The order established a White House Women's Health Task Force and directed HHS and NIH to create a Women's Health Division within NIH — a potential policy tailwind for women's health-focused companies like Daré. The company reiterated that prescription dispensing of DARE to PLAY Sildenafil Cream, a 503B compounded product, is expected to begin this quarter.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.